Amnesty International Report on U.S. Maternal Health

Amnesty International may be best known to American audiences for bringing to light horror stories abroad such as the disappearance of political activists in Argentina or the abysmal conditions inside South African prisons under apartheid. But in a new report on pregnancy and childbirth care in the U.S., Amnesty details the maternal-health care crisis in this country as part of a systemic violation of women’s rights.

Share

Clinton: Karzai runoff win likely, but he must deliver

With a runoff presidential election in Afghanistan appearing likely, Secretary of State Hillary Clinton told CNN on Friday that she expects the current president, Hamid Karzai, to win. “It is likely that they will find that President Karzai got very close to the 50-plus-1” in August’s balloting, she said in an exclusive CNN interview, referring to the 50 percent plus one vote needed to avoid a runoff.

Share

Study: Tamiflu may do children more harm than good

Treating flu-stricken children with anti-viral medication including Tamiflu and Relenza could do more harm than good, a new report has warned. Researchers from the University of Oxford found that while the anti-virals reduced the duration of illness by up to one day and a half, they had “little or no effect” on the likelihood of the children developing complications. The researchers conceded that they didn’t know the extent to which their report applied to the current swine flu pandemic, but said, “based on current evidence, the effects of anti-virals on reducing the course of illness or preventing complications might be limited.” In compiling their report, published in the British Medical Journal, the Oxford University researchers searched the world for trials of Tamiflu and Relenza on children under 12.

Share

Study: First Test for Colon Cancer Recurrence

Researchers from the University of Oxford announced on Thursday that they have developed the first genetic test for predicting the likelihood that a patient’s colon cancer will recur. The test, which scans for mutations in 12 genes expressed by colon tumors, can tell patients in the early stages of colon cancer the chances that their disease will come back after treatment.

Share